BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25903140)

  • 1. Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.
    Puto LA; Brognard J; Hunter T
    J Biol Chem; 2015 Jun; 290(25):15406-15420. PubMed ID: 25903140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.
    Pan WW; Zhou JJ; Liu XM; Xu Y; Guo LJ; Yu C; Shi QH; Fan HY
    J Biol Chem; 2013 May; 288(19):13620-30. PubMed ID: 23539629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Prognostic Role for SPOP, DAXX, RARRES1, and LAMP2 as an Autophagy Related Genes in Prostate Cancer.
    Jamali L; Moradi A; Ganji M; Ayati M; Kazeminezhad B; Fazeli Attar Z; Ghaedi H; Ghaderian SMH; Fallah-Karkan M; Ranjbar A
    Urol J; 2020 Mar; 17(2):156-163. PubMed ID: 30882175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy.
    Li GM; Li L; Li MQ; Chen X; Su Q; Deng ZJ; Liu HB; Li B; Zhang WH; Jia YX; Wang WJ; Ma JY; Zhang HL; Xie D; Zhu XF; He YL; Guan XY; Bi J
    Cell Death Differ; 2021 Mar; 28(3):952-967. PubMed ID: 33037394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx.
    Wethkamp N; Hanenberg H; Funke S; Suschek CV; Wetzel W; Heikaus S; Grinstein E; Ramp U; Engers R; Gabbert HE; Mahotka C
    J Biol Chem; 2011 Jun; 286(22):19576-88. PubMed ID: 21482821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs.
    Ueda H; Akiyama Y; Shimada S; Mogushi K; Serizawa M; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Tanabe M; Tanaka S
    Endocr Relat Cancer; 2018 Jun; 25(6):619-631. PubMed ID: 29599123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation.
    Puto LA; Reed JC
    Genes Dev; 2008 Apr; 22(8):998-1010. PubMed ID: 18413714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.
    de Wilde RF; Heaphy CM; Maitra A; Meeker AK; Edil BH; Wolfgang CL; Ellison TA; Schulick RD; Molenaar IQ; Valk GD; Vriens MR; Borel Rinkes IH; Offerhaus GJ; Hruban RH; Matsukuma KE
    Mod Pathol; 2012 Jul; 25(7):1033-9. PubMed ID: 22575867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine represses DAXX gene transcription and induces cancer cell apoptosis.
    Li J; Gu L; Zhang H; Liu T; Tian D; Zhou M; Zhou S
    Lab Invest; 2013 Mar; 93(3):354-64. PubMed ID: 23295648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program.
    McDonough H; Charles PC; Hilliard EG; Qian SB; Min JN; Portbury A; Cyr DM; Patterson C
    J Biol Chem; 2009 Jul; 284(31):20649-59. PubMed ID: 19465479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.
    Tang J; Agrawal T; Cheng Q; Qu L; Brewer MD; Chen J; Yang X
    PLoS One; 2013; 8(2):e55813. PubMed ID: 23405218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
    Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
    Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase.
    Feng Z; Wang L; Sun Y; Jiang Z; Domsic J; An C; Xing B; Tian J; Liu X; Metz DC; Yang X; Marmorstein R; Ma X; Hua X
    Cancer Res; 2017 Jan; 77(2):401-411. PubMed ID: 27872097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death-associated protein 6 (Daxx) mediates cAMP-dependent stimulation of Cyp11a1 (P450scc) transcription.
    Lan HC; Wu CF; Shih HM; Chung BC
    J Biol Chem; 2012 Feb; 287(8):5910-6. PubMed ID: 22199361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors.
    Shi Y; Jin J; Wang X; Ji W; Guan X
    Neoplasia; 2019 Jun; 21(6):533-544. PubMed ID: 31029033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
    Singh K; Sharma A; Mir MC; Drazba JA; Heston WD; Magi-Galluzzi C; Hansel D; Rubin BP; Klein EA; Almasan A
    Mol Cancer; 2014 Mar; 13():70. PubMed ID: 24655592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
    Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
    Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.
    Tsourlakis MC; Schoop M; Plass C; Huland H; Graefen M; Steuber T; Schlomm T; Simon R; Sauter G; Sirma H; Minner S
    Hum Pathol; 2013 Sep; 44(9):1789-96. PubMed ID: 23642739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.